Antidote Health Funding: $34M Raised, Series A (2022)
Antidote Health is a Healthtech company based in New York, NY. It has raised $34M in total funding. Latest round: Series A.
Antidote Health funding overview
Antidote Health is a Healthtech company based in New York, NY. Antidote Health has raised $34M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2022. The round record for Antidote Health runs through 2022; nothing later has been disclosed. Investors on record include iAngels, Group 11, Flint Capital. 3 distinct backers are named across the disclosed rounds.
Antidote Health at a glance
Total raised
$34M
Latest round
Series A
Latest round date
March 2022
Industry
Healthtech
Headquarters
New York, NY
Notable investors
iAngels, Group 11, Flint Capital
Frequently asked about Antidote Health funding
How much has Antidote Health raised?
Antidote Health has raised $34M in total disclosed funding across the rounds on record.
Who has invested in Antidote Health?
iAngels, Group 11, Flint Capital are named among the investors backing Antidote Health.
What was the latest Antidote Health funding round?
The most recent disclosed round is a Series A, announced in March 2022.
Where is Antidote Health based?
Antidote Health is based in New York, NY.
What sector does Antidote Health operate in?
Antidote Health is tracked under Healthtech from New York, NY, with $34M in disclosed funding.
When did Antidote Health last raise?
The last disclosed Antidote Health round closed in March 2022 at Series A.
Antidote Health totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Healthtech companies in New York below to benchmark round size and investor mix.
